GlaxoSmithKline plc Share Price and Company Fundamentals



Price
£1388.2
Change
-6.800 (-0.487%)
52 week
1190.8 - 1528.8

Last traded: Last Friday at 3:35 PM

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Key Metrics

PE ratio

15.99

PB ratio

451.89

Dividend yield

0.06%

Beta

0.38

Market cap

£69.85B

Enterprise value

£97.6B

Company profile

Industry / SectorDrug Manufacturers—General / Healthcare
Full time employees94066
Websitehttp://www.gsk.com
Mailing address980 Great West Road Brentford TW8 9GS United Kingdom
Phone / Fax44 20 8047 5000 /

Dividends

Dividend yield

0.06%

Dividend amount

£0.80

Payout ratio

92.27%

5Y Avg. yield

5.31%

GlaxoSmithKline plc paid £0.80 dividend and the ex-dividend date was 19 Aug 2021.The dividend payout ratio is 92.27%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.GSK dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.

GSK's forward dividend amount is £0.8 and the forward dividend yield is 5.76%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Sep 2021, following are the company executives and directors listed on GlaxoSmithKline plc.

NameTitleAgeTotal Pay
Ms. Emma N. WalmsleyCEO & Director502.75M
Mr. Iain James MackayCFO & Exec. Director582.01M
Dr. Hal V. BarronChief Scientific Officer, Pres of R&D and Director574.83M
Ms. Karenann K. TerrellChief Digital & Technology Officer58
Ms. Sarah Elton-FarrHead of Investor Relations
Mr. James FordSr. VP & Gen. Counsel
Ms. Sally JacksonSr. VP of Global Communications & CEO Office
Ms. Diana ConradSr. VP of HR
Mr. David Simon RedfernChief Strategy Officer54
Mr. Herve GisserotHead of Pharmaceuticals for Asia-Pacific

Profitability and management effectiveness

Profit margin

13.34%

Operating margin

24.85%

Return on assets

6.32%

Return on equity

24.29%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of GlaxoSmithKline plc is 69.85B and its enterprise value is 97.6B. The enterprise value to revenue ratio of GSK is 2.97.

The GSK's stocks Beta value is 0.38 making it 62% less volatile compared to LSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

GlaxoSmithKline plc (LSE:GSK) Frequently Asked Questions

1. What is GlaxoSmithKline plc's Stock Symbol?

GlaxoSmithKline plc trades on LSE under the ticker symbol "GSK".

2. What is GlaxoSmithKline plc's stock price today?

One share of GSK stock can currently be purchased for approximately £1388.2.

3. How can I contact GlaxoSmithKline plc?

GlaxoSmithKline plc's mailing address is 980 Great West Road Brentford TW8 9GS United Kingdom. The company can be reached via phone at 44 20 8047 5000.

4. What is GlaxoSmithKline plc's official website?

The official website of GlaxoSmithKline plc is http://www.gsk.com.